Kodak Company Flips to Pharma

A Kodak moment for the books: the former film giant flipped to pharma in a move aimed to rejuvenate the company after nearly two decades of hardship. Several reports state that Kodak branched out to offset the large-scale loss of its film business – punctuated by a bankruptcy in 2012 after the concept of the digital camera that it invented rendered many of its product offerings obsolete.

Initial talks of Kodak’s new active pharmaceutical ingredients (APIs) division, branded “Kodak Pharmaceuticals,” began as early as a few months ago according to Kodak CEO Jim Continenza. He says the move shouldn’t be all that surprising.

Read More

Gone in a New York Minute: How the Amazon Deal Fell Apart

In early November, word began to leak that Amazon was serious about choosing New York to build a giant new campus. The city was eager to lure the company and its thousands of high-paying tech jobs, offering billions in tax incentives and lighting the Empire State Building in Amazon orange.…

Read More